GlassScriptPhysician profile
Steven Schwartz
NPI 1275574832
$2,571.47
in general payments reported to CMS, 2019-2025
11 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,140 · 2021: $232 · 2022: $13.80 · 2023: $16.88 · 2024: $33.16 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $897.89 | 2019-2021 | |
| Davol INC. | $501.86 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $303.40 | 2019 | |
| Abiomed | $227.40 | 2019-2021 | |
| Philips North America LLC | $184.30 | 2019-2021 | |
| Baxter Healthcare | $135.41 | 2025 | Floseal |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2019 | |
| Pinnacle Biologics, INC | $84.19 | 2019 | |
| Edwards Lifesciences Corporation | $61.99 | 2019-2022 | |
| Medtronic, INC. | $33.16 | 2024 | Corevalve Evolut R |
| Cvrx, INC. | $16.88 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.